Strategy Board

The Strategy Board (SB) represents the stakeholders within OSIPI and maintains the Strategic Plan outlining the mission, aims and general approach of OSIPI. If needed the SB will also propose changes to the OSIPI governance for approval by the ISMRM perfusion study group.

The SB consists of the OSIPI leadership team and representatives from the ISMRM board, ISMRM Perfusion Study Group, and any number of advisory members representing other bodies/societies with an interest in open science and reproducibility.  This could include other ISMRM study groups, other societies or more informal networks. These are currently the perfusion committees of QIBA RSNA (QIBA ASL committee, QIBA DSC committee, and QIBA DCE committee governing committee).

If you are interested in joining the SB, please contact the OSIPI chair.

OSIPI Strategic Plan: Current version 1.

OSIPI Governance: Current version 1.0

SB meetings

• May 2021: first SB meeting
• Feb 2023: second SB meeting
• Jan 2024: upcoming SB meeting